symptoms and mucosal lesions associated with gastro-oesophageal reflux
impaired gastric motility symptom relief secondary to systemic conditions:
diabetes mellitus
autonomic neuropathy
systemic sclerosis
short-term management of non-ulcer dyspepsia
although cisapride is frequently used in children, particularly for the treatment of infantile gastro- oesophageal reflux, because of the risk of QT interval prolongation, cisapride is specifically contra - indicated in premature infants for up to 3 months after birth. Also in children up to the age of 12 years, there are insufficient data to support the use of cisapride.
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page